The data suggests a declining trend in stomach malignant neoplasms mortality among Canadian women. Starting from a rate of 2.9 female deaths per hundred thousand in 2024, forecasts predict a decrease to 2.5 by 2028. This reflects a year-on-year decline of approximately 3.4% over each subsequent year. The cumulative annual growth rate (CAGR) over this forecast period is approximately -3.6%, indicating a steady reduction in mortality.
Future trends to watch for include the impact of advancements in targeted therapies and early detection, as well as lifestyle changes and public health initiatives all contributing to this downward trend. Monitoring these factors could further inform projections and facilitate policy planning.
